• 

  Alzheimer’s Drugs and ARIA: Leqembi ‘Brain Bleeds’ Side Effect, Explained
• 

  No More Aduhelm: Biogen Halts Sales of Alzheimer’s Drug
• 

  FAQ: What Is Alzheimer’s Drug Leqembi, Where Is It Approved, and More
• 

  With Full FDA Approval, Alzheimer’s Drug Leqembi Now Covered By Medicare
• 

  Is Leqembi Safe? What to Know About the New Alzheimer’s Drug’s Side Effects
• 

  At AAIC, We Tracked Down Answers to Readers’ Alzheimer’s Drug Questions
• 

  Phil’s Journal: What Is ‘Quality of Life?’ A Sad Farewell and a Tough Deciscion
• 

  The Next Anti-Amyloid in the Alzheimer’s Pipeline: Donanemab
• 

  What Do YOU Know About the New Generation of Alzheimer’s Drugs?
• 

  Sneak Peek of Trial Data for Alzheimer’s Drug Donanemab
• 

  Why Is This New Generation of Alzheimer’s Drugs Such a Big Deal?
• 

  On the Verge of Full FDA Approval, New Details About Leqembi Death
• 

  Medicare Stands Firm: No Public Coverage for New Alzheimer’s Drugs
• 

  FDA Declines Rush Request for Alzheimer’s Drug Donanemab
• 

  Lecanemab Approved: New Disease-Modifying Alzheimer’s Drug Leqembi on the Market

Previous123Next